Efficacy of the blocker of AT - angiotensin II receptors of valsartan in arterial hypertension
Evidence of the effectiveness of angiotensin II receptor blockers, obtained over the past decade in many clinical studies, has significantly expanded the indications for their use. The preservation of the effect of ATII on type 2 receptors, which exert a vasodilating, antiproliferative effect, slowing the progression of cardiomyocyte hypertrophy, and the absence of undesirable effects due to an increase in the activity of the bradykinin system in Sartwal (valsartan) can reduce the risk of cardiovascular complications, improve the prognosis and quality of life of patients with arterial hypertension.